NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Ra Medical Systems, Inc. (NYSE: RMED) resulting from allegations that Ra Medical may have issued materially misleading business information to the investing public.
In September 2018, Ra Medical completed its initial public offering, issuing around 4.5 million shares of common stock priced at $17.00 per share. Then, on March 14, 2019, Ra Medical revealed that its fourth quarter 2018 financial results had been negatively impacted by issues related to the hiring and training of qualified sales personnel and certain production limitations. On this news, Ra Medical's stock price fell $2.14 per share, or almost 32.6%, to close at $4.43 per share on March 15, 2019.
Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Ra Medical investors. If you purchased shares of Ra Medical please visit the firm’s website at http://www.rosenlegal.com/cases-register-1590.html to join the class action. You may also contact Phillip Kim of Rosen Law Firm toll free at 866-767-3653 or via email at firstname.lastname@example.org or email@example.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has secured hundreds of millions of dollars for investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.